Towards Healthcare
Infectious Disease Diagnostics Market to Surge USD 62.95 Bn by 2034

Infectious Disease Diagnostics Market Evolution 2025 From Laboratory-Based to Point-of-Care Transformation

Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more reliable detection methods to control outbreaks. Growing awareness, government initiatives, and technological innovations in diagnostic tools are also fueling growth.

Content

  • Insight Code: 6012
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The infectious disease diagnostics market is worth USD 27.43 billion in 2025, and by 2034, it is forecasted to hit USD 62.95 billion, registering a CAGR of 9.67% over the decade.

North America is currently leading the infectious disease diagnostics market due to its robust healthcare system, advanced laboratory infrastructure, and strong focus on technological innovation.

Some key players include Illumina, Quest Diagnostics, PerkinElmer, Sysmex Corporation, MedMira, Lucira Health 

Key trends include the growth due to healthcare providers seeking faster, more reliable detection methods to control outbreaks.

They allow timely and accurate detection, enabling early treatment, outbreak management, and infection control.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions